Submitted by Anonymous (not verified) on 2 August 2024 - 15:02
Human medicines European public assessment report (EPAR): Tizveni, tislelizumab, Date of authorisation: 19/04/2024, Status: Withdrawn (authorisation)
Source:
Human medicines European public assessment report (EPAR): Tizveni, tislelizumab, Date of authorisation: 19/04/2024, Status: Withdrawn (authorisation)